Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
6.03
+0.18 (3.08%)
At close: Nov 6, 2026, 4:00 PM EST
6.10
+0.07 (1.16%)
After-hours: Nov 6, 2026, 7:39 PM EST
Alumis Revenue
Alumis had revenue of $1.66M in the quarter ending June 30, 2026, a decrease of -37.66%. This brings the company's total for the last twelve months to $7.40M, down -63.11% year-over-year. In the year 2025, Alumis had annual revenue of $24.05M. That makes Alumis the 38,646th largest company in the world by revenue and 5,082nd in the United States.
Revenue (ttm)
$7.40M
Revenue Growth
-63.11%
P/S Ratio
105.50
Revenue / Employee
$30,954
Employees
239
Market Cap
780.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.05M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ALMS News
- 4 weeks ago - Alumis announces new envudeucitinib data from ONWARD clinical program - TheFly
- 4 weeks ago - Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures - GlobeNewsWire
- 7 weeks ago - Alumis Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 1 month ago - Alumis Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 2 months ago - Alumis Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 2 months ago - Alumis to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 2 months ago - Alumis downgraded to Neutral from Buy at Guggenheim - TheFly
- 2 months ago - Alumis rises 10.7% - TheFly